source
- Beeline Medicines reports promising Phase 2 lupus dataBeeline Medicines, a Bain‑backed startup, announced encouraging mid‑stage results for its lupus candidate afimetoran, a drug originally sourced from Bristol Myers Squibb. The Phase 2 trial data we…
- Advancing New Approach Methodologies: Building Standards and Evidence to Boost Preclinical AdoptionNew Approach Methodologies (NAMs) are being hailed as a way to transform preclinical research and toxicology, but their wider use has been hampered by three key barriers: sourcing appropriate cells…